Stephen A. Hurly
2018
In 2018, Stephen A. Hurly earned a total compensation of $1.2M as Former President and Chief Executive Officer at Eleven Biotherapeutics, a 12% increase compared to previous year.
Compensation breakdown
| Option Awards | $248,202 |
|---|---|
| Salary | $264,808 |
| Other | $682,293 |
| Total | $1,195,303 |
Hurly received $682.3K in other compensation, accounting for 57% of the total pay in 2018.
Hurly also received $248.2K in option awards and $264.8K in salary.
Rankings
In 2018, Stephen A. Hurly's compensation ranked 8,306th out of 14,244 executives tracked by ExecPay. In other words, Hurly earned more than 41.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,306 out of 14,244 | 42nd |
Division Manufacturing | 3,290 out of 5,765 | 43rd |
Major group Chemicals And Allied Products | 1,235 out of 2,128 | 42nd |
Industry group Drugs | 1,031 out of 1,817 | 43rd |
Industry Pharmaceutical Preparations | 803 out of 1,391 | 42nd |
Source: SEC filing on April 30, 2019.
Hurly's colleagues
We found three more compensation records of executives who worked with Stephen A. Hurly at Eleven Biotherapeutics in 2018.